4
Changes in Ownership
Xilio Therapeutics, Inc. Filed Acc 0000899243-21-047829
10% owner bought 42,469 shares at an average $9.66 ($410,161)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC 10% owner | 2021-12-08 | Purchase | +13,458 | $9.62 | $129,474 | 2,776,402 | I: show line 1 in the form |
| Bain Capital Life Sciences Investors, LLC 10% owner | 2021-12-09 | Purchase | +4,011 | $9.84 | $39,485 | 2,780,413 | I: show line 2 in the form |
| Bain Capital Life Sciences Investors, LLC 10% owner | 2021-12-10 | Purchase | +21,812 | $9.56 | $208,564 | 2,802,225 | I: show line 3 in the form |
| Bain Capital Life Sciences Investors, LLC 10% owner | 2021-12-10 | Purchase | +3,188 | $10.24 | $32,638 | 2,805,413 | I: show line 4 in the form |
| Open-market purchases · 42,469 sh · avg $9.66 · $410,161 | |||||||
Loading xslF345X03/doc4.xml…